Oncorus is a pre-clinical stage biotechnology company developing innovative and impactful, next-generation oncolytic HSV products with unprecedented potential to recruit all arms of immune system to treat solid tumors.

The Oncorus family is dedicated to bringing hope and impactful therapies to cancer patients everywhere.  As part of our commitment, we have taken a pledge to donate a portion of product sales to fund promising cancer research and to support cancer care in the developing world.


Fierce 15

LATEST NEWS


WHO WE ARE

Meet the leadership team and well-known biotechnology entrepreneurs and learn about the mission of Oncorus. Learn More →

JOIN THE TEAM

This is an exciting time in the development and formation of Oncorus.  Joining us now means having the opportunity to get in on the ground floor and make a visible impact.   Find Out How →